CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 42 enrolled
Drug / intervention
Cryo-Touch IIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01167140
NCT01167140Phase 3Completed

Cryo-Touch II for the Treatment of Wrinkles

Pacira Pharmaceuticals, Inc·interventional·Posted Jul 22, 2010·Updated Jan 24, 2024

In Brief

A Phase 3 clinical trial evaluating Cryo-Touch II for Facial Wrinkles. Completed, enrolled 42 participants across 1 site.

Detailed Summary

This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFacial Wrinkles
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 22, 2010
Enrollment StartJul 1, 2010
Primary CompletionJan 1, 2011
Study CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.9 years ago

Interventions

Cryo-Touch IIdevice

Percutaneous treatment with the device